The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A10 | Drugs used in diabetes | |
| 3 | A10A | Insulins and analogues | |
| 4 | A10AC | Insulins and analogues for injection, intermediate-acting |
| Code | Title | |
|---|---|---|
| A10AC01 | Insulin (human) | |
| A10AC02 | Insulin (beef) | |
| A10AC03 | Insulin (pork) | |
| A10AC04 | Insulin lispro | |
| A10AC30 | Combinations |
| Active Ingredient | Description | |
|---|---|---|
| Insulin (human) |
The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. |
|
| Insulin (pork) |
|
|
| Insulin lispro |
The primary activity of insulin lispro is the regulation of glucose metabolism. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| HUMULIN I Suspension for injection in a vial | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| HYPURIN Suspension for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| INSULATARD Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
